High Fermentation Titer and Yield
Rerouting carbon flux and enzyme overexpression leads to a faster production rate and higher final concentration , solving the low yield issue.
Alanine is a non-essential amino acid widely used in the food industry as a flavoring agent and in pharmaceuticals (e.g., infusion solutions). While L-Alanine can be produced via microbial fermentation, commercial viability is challenged by the low acid production rate in fermentation , leading to extended cycle times and high operational costs. Furthermore, conventional downstream processing is hindered by high extraction cost , particularly the need for complex separation processes to isolate the pure amino acid from the complex fermentation broth. Biosynthesis optimization offers a cleaner, higher-yield route.
CD Biosynsis offers a synthetic biology service focused on highly efficient Alanine production in Corynebacterium glutamicum, a powerful host for amino acid biosynthesis. Our core strategy involves metabolic regulation modification in Corynebacterium glutamicum . We genetically engineer the host to maximize the carbon flux from glucose toward pyruvate, a direct precursor for Alanine. This is achieved by deleting competing pathways (e.g., lactate or succinate production) and reinforcing rate-limiting steps in glycolysis. Crucially, this is coupled with overexpression of alanine dehydrogenase . We introduce and heavily overexpress a highly active Alanine Dehydrogenase (AlaDH) enzyme. AlaDH efficiently converts pyruvate directly into L-Alanine, the desired product, using NADH or NADPH as a cofactor, ensuring rapid, high-titer conversion and maximizing the final product concentration. This integrated approach aims to deliver high-titer, high-purity Alanine, significantly reducing both fermentation time and downstream purification expenses.
Get a QuoteDeveloping a cost-effective Alanine production route faces these key limitations:
A successful solution must force the metabolic flux toward pyruvate and maximize the efficiency of the final enzymatic conversion step.
CD Biosynsis utilizes advanced metabolic and enzyme engineering to optimize Alanine production in C. glutamicum:
Metabolic Regulation Modification in C. glutamicum
We delete competing pathways (ldh, pox, ppc) and overexpress key glycolytic enzymes (e.g., pyk) to channel maximum carbon flux from glucose directly to pyruvate.
Overexpression of Alanine Dehydrogenase
We introduce and overexpress a highly active, heterologous Alanine Dehydrogenase (AlaDH) under a strong promoter to ensure the rapid and efficient conversion of Pyruvate to L-Alanine.
Cofactor Engineering for NADH/NADPH Balance
We engineer the host's redox systems (e.g., transhydrogenase) to ensure optimal regeneration of the NADH/NADPH cofactor required by the overexpressed AlaDH.
Feed and Process Optimization
We develop optimized fed-batch strategies (e.g., continuous NH3 addition) to maintain the optimal pH and substrate concentration, minimizing product inhibition and maximizing titer.
This systematic approach is focused on rebuilding the central metabolism of C. glutamicum to function as a highly efficient L-Alanine production machine.
Our Alanine engineering service is dedicated to pursuing the following production goals:
High Fermentation Titer and Yield
Rerouting carbon flux and enzyme overexpression leads to a faster production rate and higher final concentration , solving the low yield issue.
Reduced Downstream Costs
Higher initial titer simplifies purification processes and lowers the total extraction cost , addressing the second major pain point. [Image of Cost Reduction Icon]
High Optical Purity
Enzymatic synthesis using AlaDH naturally yields high purity L-Alanine , avoiding the need for chiral resolution required in chemical synthesis.
Established Industrial Host
C. glutamicum is a non-pathogenic, generally recognized as safe (GRAS) organism with decades of use in large-scale amino acid production.
Sustainable Production
Uses renewable carbon sources (e.g., glucose) as feedstocks, promoting an environmentally friendly biomanufacturing process.
We provide a sustainable and cost-effective biosynthetic platform for industrial L-Alanine production.
Our Alanine strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and pathway efficiency.
Explore the potential for a high-titer, high-purity Alanine supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is Corynebacterium glutamicum a good host for Alanine?
C. glutamicum is a non-sporulating, non-pathogenic bacterium widely used in industry for high-yield amino acid production (e.g., Glutamate, Lysine). It has a robust central metabolism that can be easily engineered to favor Alanine synthesis.
What is the main advantage of using Alanine Dehydrogenase?
AlaDH catalyzes the direct, single-step reductive amination of pyruvate to L-Alanine . This is a highly specific, high-yield reaction that ensures the product is the desired L-enantiomer, leading to high optical purity.
Which competing pathways must be removed?
The main competing pathways consume pyruvate, the Alanine precursor. These include pathways leading to Lactate (via ldh), Acetate (pox), and other organic acids (ppc, pyc), which must be deleted or downregulated to maximize Alanine flux.
How does a higher titer reduce extraction cost?
When the final product concentration (titer) is higher, the downstream purification process requires less volume of broth to be processed , saving energy, water, and consumables used in filtration, separation, and solvent recovery steps.
What is the estimated project timeline?
A project involving multi-gene metabolic engineering, enzyme overexpression, and fed-batch optimization typically requires 20-24 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.